3:00 pm – 3:50 pm
Baltimore Convention Center
Pierre-Jean Lamy, PharmD, PhD, Medical Director, Laboratoire de Biologie Medicale, Imagenome
Eduardo Castro-Echeverry, MD, Resident Physician – Pathology, Baylor Scott & White
Darryl Irwin, PhD, Senior Director, Scientific Affairs, Agena Bioscience
In this two-part seminar, Dr. Pierre-Jean Lamy, from Imagenome in Montpellier, France will first review the results of his liquid biopsy study, which entails a head-to-head comparison between Agena’s UltraSEEK liquid biopsy chemistry and the Roche Cobas EGFR v2 Mutation Test. Dr. Lamy will also present the correlation of tumor-matched plasma samples with UltraSEEK. The second half of the seminar will feature Dr. Eduardo Castro, from Baylor Scott & White, in Dallas, Texas. Here, Dr. Castro will discuss how he validated solid tumor profiling panels and outline the decision criteria that led to choosing the MALDI-TOF platform.
If you’re unable to attend, we encourage you to register and provide your email as we will follow-up with the workshop recording and supplemental materials.
Agena Bioscience enables clinical laboratories world-wide to deliver affordable targeted genomic testing. Our team will be at AMP 2019, and we’re excited to engage in dialogue with you!
With exception of the MassARRAY® Dx, all other products are For Research Use Only. Not for use in diagnostic procedures.